Study on safety of Unani pharmacopeial formulation Qurs Kusta Khabas- al- Hadeed and Habb- e-Marwareed in cases of Sailanur Reham (Leucorrhoea)

Authors

  • Priyanka Verma Research Officer, Regional Research Institute of Unani Medicine, Jamia Nagar, New Delhi, India

DOI:

https://doi.org/10.37591/rrjopc.v8i1.962

Abstract

Leucorrhoea is nothing but excessive vaginal discharge, it is common gynaecological complaint . Main objective of the present study was to study safety parameter of Unani formulation Qurs-e- Kusta Khubs al Hadeed and Habb-e-Marwarweed in cases of Sayalan-al-Rahim (Leucorrhoea).Study was jointly conducted in the laboratory at Regional Research Institute of Unani Medicine, New Delhi. For this 56 females patientsin the age group of 18-60 years presenting sign and symptom with excessive white discharge was taken in this study.Laboratory investigations were performed at day one and at the end of the study i.e. 6 weeks. Statistical analysis was done using Students ‘T’ test, significance level of P < 0.05 was used in this study. There was marginal increase in Hb and red blood cells (p > 0.05), with increase (p >0.05 ) in TLC, lymphocytes, SGOT, SGPT, urea and decrease ( p > 0.05 ) in neutrophil, eosinophil, monocyte, bilirubin, alkaline phosphatise and no change in creatinine level. These changes fall in normal range, so it can be concluded that Qurs Kusta Khaba-al- Hadeed and Habb-e- Marwareed is safe as it did not induce any toxic effect, particularly on kidney and liver functions and is safe for consumption.

Downloads

Published

2021-04-15

Issue

Vol. 8 No. 1 (2021)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.